Jane Street Group LLC Takes $30,000 Position in MediciNova, Inc. (NASDAQ:MNOV)

Jane Street Group LLC bought a new position in MediciNova, Inc. (NASDAQ:MNOV) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 14,138 shares of the biopharmaceutical company’s stock, valued at approximately $30,000.

MediciNova Price Performance

Shares of MNOV opened at $1.87 on Friday. The business’s 50 day simple moving average is $2.06 and its 200-day simple moving average is $1.74. The company has a market capitalization of $91.72 million, a P/E ratio of -8.90 and a beta of 0.84. MediciNova, Inc. has a one year low of $1.12 and a one year high of $2.55.

Analyst Ratings Changes

A number of research firms recently weighed in on MNOV. D. Boral Capital started coverage on shares of MediciNova in a research note on Monday, December 2nd. They issued a “buy” rating and a $9.00 target price on the stock. StockNews.com assumed coverage on shares of MediciNova in a report on Friday, January 10th. They issued a “hold” rating on the stock.

MediciNova Profile

MediciNova, Inc, a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID.